Human VEGF-C(Vascular Endothelial Growth Factor C) ELISA Kit
中文名称:人血管内皮细胞生长因子C(VEGF-C)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 109.38-7000 pg/mL
- 灵敏度: 65.63 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人VEGF-C抗体包被于酶标板上,实验时样品(或标准品)中的人VEGF-C会与包被抗体结合。后依次加入生物素化的抗人VEGF-C抗体和辣根过氧化物酶标记的亲和素,抗人VEGF-C抗体与结合在包被抗体上的人VEGF-C结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,VEGF-C浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中VEGF-C的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 109.38-7000 pg/mL |
灵敏度 | 65.63 pg/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人VEGF-C,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1
IF: 16.200 -
Melatonin decreases GSDME mediated mesothelial cell pyroptosis and prevents peritoneal fibrosis and ultrafiltration failure
IF: 9.100 -
Fucoxanthin inhibits gastric cancer lymphangiogenesis and metastasis by regulating Ran expression
IF: 7.900 -
Evaluation of maternal serum vascular endothelial growth factor C and D levels in intrahepatic cholestasis of pregnancy
IF: 3.800Journal: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)PMID:37680091Reactivity:HumanSample Type:plasma -
Association between the serum concentrations and mutational status of IL?8, IL?27 and VEGF and the expression levels of the hERG potassium channel gene in patients with colorectal cancer
IF: 2.967 -
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells
IF: 4.135Journal: Chinese Journal of Cancer Research (2020)PMID:33223752Reactivity:HumanSample Type:Cell culture supernatant -
The RNA-binding protein QKI suppresses tumorigenesis of clear cell renal cell carcinoma by regulating the expression of HIF-1α
IF: 3.565Journal: Journal of Cancer (2020)PMID:32047543Reactivity:HumanSample Type:Cell culture supernatant -
Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis
IF: 3.060